172 related articles for article (PubMed ID: 30093633)
1. Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma.
Shao YW; Wood GA; Lu J; Tang QL; Liu J; Molyneux S; Chen Y; Fang H; Adissu H; McKee T; Waterhouse P; Khokha R
Oncogene; 2019 Jan; 38(2):291-298. PubMed ID: 30093633
[TBL] [Abstract][Full Text] [Related]
2. Novel promoters and coding first exons in DLG2 linked to developmental disorders and intellectual disability.
Reggiani C; Coppens S; Sekhara T; Dimov I; Pichon B; Lufin N; Addor MC; Belligni EF; Digilio MC; Faletra F; Ferrero GB; Gerard M; Isidor B; Joss S; Niel-Bütschi F; Perrone MD; Petit F; Renieri A; Romana S; Topa A; Vermeesch JR; Lenaerts T; Casimir G; Abramowicz M; Bontempi G; Vilain C; Deconinck N; Smits G
Genome Med; 2017 Jul; 9(1):67. PubMed ID: 28724449
[TBL] [Abstract][Full Text] [Related]
3. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
4. Circ0106714 inhibits tumorigenesis of colorectal cancer by sponging miR-942-5p and releasing DLG2 via Hippo-YAP signaling.
Li S; Yan G; Liu W; Li C; Wang X
Mol Carcinog; 2020 Dec; 59(12):1323-1342. PubMed ID: 33128289
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.
Zhuang RJ; Bai XX; Liu W
Cancer Biol Ther; 2019; 20(6):897-911. PubMed ID: 30862230
[TBL] [Abstract][Full Text] [Related]
6. The genomic landscape of canine osteosarcoma cell lines reveals conserved structural complexity and pathway alterations.
Megquier K; Turner-Maier J; Morrill K; Li X; Johnson J; Karlsson EK; London CA; Gardner HL
PLoS One; 2022; 17(9):e0274383. PubMed ID: 36099278
[TBL] [Abstract][Full Text] [Related]
7. Distinct mechanisms of PTEN inactivation in dogs and humans highlight convergent molecular events that drive cell division in the pathogenesis of osteosarcoma.
Sarver AL; Mills LJ; Makielski KM; Temiz NA; Wang J; Spector LG; Subramanian S; Modiano JF
Cancer Genet; 2023 Aug; 276-277():1-11. PubMed ID: 37267683
[TBL] [Abstract][Full Text] [Related]
8. 11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma.
Siaw JT; Javanmardi N; Van den Eynden J; Lind DE; Fransson S; Martinez-Monleon A; Djos A; Sjöberg RM; Östensson M; Carén H; Trøen G; Beiske K; Berbegall AP; Noguera R; Lai WY; Kogner P; Palmer RH; Hallberg B; Martinsson T
Cell Rep; 2020 Sep; 32(12):108171. PubMed ID: 32966799
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors.
Levine RA; Forest T; Smith C
Vet Pathol; 2002 May; 39(3):372-8. PubMed ID: 12014501
[TBL] [Abstract][Full Text] [Related]
10. Behavioural and molecular characterisation of the Dlg2 haploinsufficiency rat model of genetic risk for psychiatric disorder.
Waldron S; Pass R; Griesius S; Mellor JR; Robinson ESJ; Thomas KL; Wilkinson LS; Humby T; Hall J; Dwyer DM
Genes Brain Behav; 2022 Apr; 21(4):e12797. PubMed ID: 35075790
[TBL] [Abstract][Full Text] [Related]
11. Low DLG2 gene expression, a link between 11q-deleted and MYCN-amplified neuroblastoma, causes forced cell cycle progression, and predicts poor patient survival.
Keane S; Améen S; Lindlöf A; Ejeskär K
Cell Commun Signal; 2020 Apr; 18(1):65. PubMed ID: 32312269
[TBL] [Abstract][Full Text] [Related]
12. Selective behavioural impairments in mice heterozygous for the cross disorder psychiatric risk gene DLG2.
Pass R; Haan N; Humby T; Wilkinson LS; Hall J; Thomas KL
Genes Brain Behav; 2022 Apr; 21(4):e12799. PubMed ID: 35118804
[TBL] [Abstract][Full Text] [Related]
13. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
14. DLG2 impairs dsDNA break repair and maintains genome integrity in neuroblastoma.
Keane S; de Weerd HA; Ejeskär K
DNA Repair (Amst); 2022 Apr; 112():103302. PubMed ID: 35217496
[TBL] [Abstract][Full Text] [Related]
15. High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenes.
Choy E; Hornicek F; MacConaill L; Harmon D; Tariq Z; Garraway L; Duan Z
Cancer; 2012 Jun; 118(11):2905-14. PubMed ID: 22006429
[TBL] [Abstract][Full Text] [Related]
16. A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations.
Angstadt AY; Thayanithy V; Subramanian S; Modiano JF; Breen M
Cancer Genet; 2012 Nov; 205(11):572-87. PubMed ID: 23137772
[TBL] [Abstract][Full Text] [Related]
17. Intra- and interspecies gene expression models for predicting drug response in canine osteosarcoma.
Fowles JS; Brown KC; Hess AM; Duval DL; Gustafson DL
BMC Bioinformatics; 2016 Feb; 17():93. PubMed ID: 26892349
[TBL] [Abstract][Full Text] [Related]
18. Canine osteosarcoma genome sequencing identifies recurrent mutations in
Gardner HL; Sivaprakasam K; Briones N; Zismann V; Perdigones N; Drenner K; Facista S; Richholt R; Liang W; Aldrich J; Trent JM; Shields PG; Robinson N; Johnson J; Lana S; Houghton P; Fenger J; Lorch G; Janeway KA; London CA; Hendricks WPD
Commun Biol; 2019; 2():266. PubMed ID: 31341965
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.
Selvarajah GT; Kirpensteijn J; van Wolferen ME; Rao NA; Fieten H; Mol JA
Mol Cancer; 2009 Sep; 8():72. PubMed ID: 19735553
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of DLG2 as a positional candidate for disposition index in African-Americans from the IRAS Family Study.
Palmer ND; Mychaleckyj JC; Langefeld CD; Ziegler JT; Williams AH; Bryer-Ash M; Bowden DW
Diabetes Res Clin Pract; 2010 Jan; 87(1):69-76. PubMed ID: 19931931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
